tiprankstipranks
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
Australian Market
Want to see AU:ACL full AI Analyst Report?

Australian Clinical Labs Ltd (ACL) Financial Statements

80 Followers

Australian Clinical Labs Ltd Financial Overview

Australian Clinical Labs Ltd's market cap is currently AU$512.93M. The company's EPS TTM is AU$0.1236; its P/E ratio is 22.25; and it has a dividend yield of 4.73%. Australian Clinical Labs Ltd is scheduled to report earnings on August 16, 2026, and the estimated EPS forecast is AU$0.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 729.52MAU$ 741.27MAU$ 689.73MAU$ 692.10MAU$ 989.30M
Gross ProfitAU$ 150.21MAU$ 270.86MAU$ 138.45MAU$ 566.02MAU$ 781.71M
Operating IncomeAU$ 61.49MAU$ 270.86MAU$ 56.91MAU$ 56.07MAU$ 267.68M
EBITDAAU$ 196.84MAU$ 81.36MAU$ 169.65MAU$ 184.93MAU$ 372.75M
Net IncomeAU$ 23.71MAU$ 32.43MAU$ 23.93MAU$ 35.90MAU$ 178.24M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 25.66MAU$ 22.12MAU$ 26.84MAU$ 20.59MAU$ 27.51M
Total AssetsAU$ 592.66MAU$ 574.84MAU$ 593.06MAU$ 578.91MAU$ 628.04M
Total DebtAU$ 337.40MAU$ 290.38MAU$ 308.90MAU$ 316.32MAU$ 262.38M
Net DebtAU$ 312.67MAU$ 268.94MAU$ 282.76MAU$ 296.36MAU$ 236.00M
Total LiabilitiesAU$ 442.90MAU$ 402.86MAU$ 415.30MAU$ 406.24MAU$ 395.49M
Stockholders' EquityAU$ 149.52MAU$ 171.35MAU$ 177.53MAU$ 172.42MAU$ 232.44M
Cash Flow
Free Cash FlowAU$ 153.73MAU$ 174.39MAU$ 153.09MAU$ 136.75MAU$ 262.83M
Operating Cash FlowAU$ 163.31MAU$ 182.80MAU$ 159.59MAU$ 143.68MAU$ 284.09M
Investing Cash FlowAU$ -9.28MAU$ -8.89MAU$ -7.25MAU$ -12.18MAU$ -72.04M
Financing Cash FlowAU$ -150.69MAU$ -178.74MAU$ -146.14MAU$ -137.88MAU$ -220.91M
Currency in AUD

Australian Clinical Labs Ltd Earnings and Revenue History

Australian Clinical Labs Ltd Debt to Assets

Australian Clinical Labs Ltd Cash Flow

Australian Clinical Labs Ltd Forecast EPS vs Actual EPS